| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SLGC | Class A Common Stock | Other | $0 | +6.8M | $0.00 | 6.8M | Sep 1, 2021 | By CMLS Holdings II LLC | F1, F2 | |
| transaction | SLGC | Class A Common Stock | Award | $0 | +9.89M | +145.43% | $0.00 | 16.7M | Sep 1, 2021 | Casdin Partners Master Fund, L.P. | F3 |
| transaction | SLGC | Class A Common Stock | Award | $25M | +2.5M | +14.98% | $10.00 | 19.2M | Sep 1, 2021 | Casdin Master Fund, L.P. | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SLGC | Warrants to purchase Class A Common Stock (right to buy) | Award | +4.35M | 4.35M | Sep 1, 2021 | Class A Common Stock | 3.87M | $11.50 | By CMLS Holdings LLC | F2, F5 | |||
| transaction | SLGC | Class B Common Stock | Options Exercise | $0 | -6.8M | -100% | $0.00* | 0 | Sep 1, 2021 | Class A Common Stock | 6.8M | By CMLS II Holdings LLC | F1, F2 |
| Id | Content |
|---|---|
| F1 | In connection with the closing (the "Closing") of the business combination (the "Business Combination") between the Issuer (which was formerly known as CM Life Sciences II Inc. or "CMLS II") and SomaLogic, Inc. ("SomaLogic"), among other things, each share of CMLS II's Class B common stock converted pursuant to the terms of such stock into shares of the Issuer's Class A Common Stock on a one-for-one basis. |
| F2 | The securities are held of record by CMLS Holdings II LLC ("CMLS Holdings II"). CMLS Holdings II is the record holder of the Class A common stock and the Class A Common Stock exercisable upon the issuance of warrants reported herein. The Board of Managers of CMLS Holdings II is comprised of Mr. Casdin and Mr. Keith Meister who share voting and investment discretion with respect to the Class A common stock held of record by CMLS Holdings II. As such, Mr. Casdin and Mr. Meister may be deemed to have or share beneficial ownership of the securities held directly by CMLS Holdings LLC. Each of Mr. Casdin and Mr. Meister disclaims beneficial ownership of these shares except to the extent of his respective pecuniary interest therein. |
| F3 | The securities reflected as beneficially owned by Casdin Partners Master Fund, L.P. in the table above were issued in connection with the consummation of the Business Combination and are owned directly by Casdin Partners Master Fund, LP and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Partners Master Fund, L.P., (ii) Casdin Partners GP, LLC, the general partner of Casdin Partners Master Fund L.P., and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. The shares held by Casdin Partners GP, LLC may be deemed to be indirectly beneficially owned by (i) Eli Casdin, the managing member of Casdin Partners GP, LLC. Mr. Casdin disclaims beneficial ownership of such securities except to the extent of its or his respective pecuniary interest therein. |
| F4 | Includes 2,500,000 shares issued in connection with the Business Combination to Casdin Master Fund, L.P. The shares may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Partners Master Fund, L.P., (ii) Casdin Partners GP, LLC, the general partner of Casdin Partners Master Fund L.P., and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. Mr. Casdin disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
| F5 | Following the completion of the Business Combination, warrants to purchase Class A Common Stock become exercisable on October 1, 2021, the date that is 30 days after the closing of the Business Combination. |